Hydrocephalus treatment
A method and compound for treatment of hydrocephalus is presented. Hepatocyte growth factor (HGF) is administered intraventricularly.
1. A method of treating communicating hydrocephalus in an animal or a human, comprising administering intraventricularly a pharmaceutical composition comprising human recombinant hepatocyte growth factor (hrHGF) to an animal or human in need thereof.
2. The method of claim 1 , wherein the pharmaceutical composition further comprises a pharmaceutically acceptable carrier.
3. The method of claim 2 , wherein the pharmaceutically acceptable carrier is at least one selected from the group consisting of a carrier material, diluent, excipient, wetting agent, buffering agent, suspending agent, lubricating agent, adjuvant, vehicle, and material for delivery system.
4. The method of claim 2 , wherein the pharmaceutically acceptable carrier is a carrier material for administering the HGF into a route of cerebrospinal fluid (CSF).